SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-049371
Filing Date
2017-02-21
Accepted
2017-02-21 07:32:02
Documents
3
Period of Report
2017-02-21
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d341187d8k.htm 8-K 15901
2 EX-99.1 d341187dex991.htm EX-99.1 15581
3 GRAPHIC g341187img001.jpg GRAPHIC 8882
  Complete submission text file 0001193125-17-049371.txt   45035
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

IRS No.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36912 | Film No.: 17623477
SIC: 2836 Biological Products, (No Diagnostic Substances)